Picture of Bb Biotech logo

BION Bb Biotech News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsBalancedMid CapSuper Stock

Swiss stocks - Factors to watch on March 22

ZURICH/BERLIN, March 22 (Reuters) - The Swiss blue-chip SMI
 .SSMI  was seen opening 0.2% higher at 10,987 points on Monday,
according to premarket indications by bank Julius Baer
 JBPRE01 .
    Here are some of the main factors that may affect Swiss
stocks:

    CREDIT SUISSE  CSGN.S 
    Credit Suisse Chief Executive Thomas Gottstein told
Bloomberg Television he'd consider a spin-off of the bank's
asset management business.  urn:newsml:reuters.com:*:nL4N2LJ0NZ
    
    SNB
    The Swiss National Bank increased its foreign currency
interventions to 110 billion Swiss francs ($118.27 billion)
during 2020, the central bank's annual report said on Monday, as
it battled renewed upward pressure on the safe-haven franc
during the COVID-19 pandemic. The SNB's spending on foreign
currencies increased from 13.2 billion francs in 2019 and was at
its highest level since 2012.
    
    EFG INTERNATIONAL  EFGN.S  
    The bank said it had appointed Harald Reczek as its new head
of investment solutions and a member of the Global Business
Committee, effective May 1. Sanjin Mohorovic was appointed as
new head of the Latin America region and member of the Global
Business Committee, effective July 1.
    
    COMPANY STATEMENTS
    * Roche Holding AG  ROG.S : Phase III study shows Tecentriq
helped people with early lung cancer live longer without their
disease returning  ROG.S 
    * Novartis AG  NOVN.S : appoints Karen Hale as chief legal
officer  NOVN.S 
    * Relief Therapeutics Holding SA  RLFB.S : Relief and Acer
Therapeutics sign collaboration and license agreement for
worldwide development and commercialization of acer-001 for the
treatment of UCDS and MSUD; Relief to potentially pay Acer up to
$36 million and royalties in exchange for net profit share and
territory rights  urn:newsml:reuters.com:*:nASN000Z5X
    * HBM Healthcare Investments AG  HBMN.S : IPOs of Instil Bio
and Connect Biopharma increase net asset value per HBM share by
CHF 4.55 (+1.5%)  urn:newsml:reuters.com:*:nASN000Z5U

    JULIUS BAER  BAER.S 
    Annual report 

    ANNUAL GENERAL MEETINGS
    SGS  SGSN.S  - 80.00 eur/shr dividend proposed    
        
    ANALYSTS' VIEWS
    
    EX-DIVIDEND
    BB BIOTECH  BION.S  - 3.60 CHF/shr dividend
    
    ECONOMY
    February M3 money supply data due around 0800 GMT
    SNB sight deposits due at 0900 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Bb Biotech

See all news